Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data

par Dillon, Patrick M, Brenin, Christiana M, Slingluff, Craig L
Publié dans Breast Cancer (Dove Med Press) (2020)

CONCORD biomarker prediction for novel drug introduction to different cancer types

par Kim, Youngchul, Dillon, Patrick M., Park, Taesung, Lee, Jae K.
Publié dans Oncotarget (2017)

Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

par Dillon, Patrick M., Chakraborty, Samhita, Moskaluk, Christopher A., Joshi, Prashant J., Thomas, Christopher Y.
Publié dans Head Neck (2015)

A Mechanistic Study of the Effect of Doxorubicin/Adriamycin on the Estrogen Response in a Breast Cancer Model

par Pritchard, Jessica E., Dillon, Patrick M., Conaway, Mark R., Silva, Corinne M., Parsons, Sarah J.
Publié 2012

Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival

par Stukenborg, George J., Blackhall, Leslie J., Harrison, James H., Dillon, Patrick M., Read, Paul W.
Publié dans Support Care Cancer (2015)

Anti-Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer

par Martin, Allison N., Dillon, Patrick M., Jones, David E., Brenin, David R., Lapides, David A.
Publié dans Case Rep Oncol Med (2017)

Efficient dose-finding for drug combination studies involving a shift in study populations

par Wages, Nolan A., Millard, Trish A., Dillon, Patrick M., Brenin, Christiana M., Petroni, Gina R.
Publié dans Contemp Clin Trials Commun (2020)

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

par Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publié 2013

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

par Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publié 2014

A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

par Dillon, Patrick M., Petroni, Gina R., Horton, Bethany J., Moskaluk, Christopher A., Fracasso, Paula M., Douvas, Michael G, Varhegyi, Nikole, Zaja-Milatovic, Snjezana, Thomas, Christopher Y.
Publié dans Clin Cancer Res (2017)

Early Palliative Care Reduces End‐of‐Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer

par Romano, Andrew M., Gade, Kristine E., Nielsen, Gradon, Havard, Robert, Harrison, James H., Barclay, Josh, Stukenborg, George J., Read, Paul W., Blackhall, Leslie J., Dillon, Patrick M.
Publié dans Oncologist (2017)

Genetically Engineered Cancer Models, But Not Xenografts, Faithfully Predict Anticancer Drug Exposure in Melanoma Tumors

par Combest, Austin J., Roberts, Patrick J., Dillon, Patrick M., Sandison, Katie, Hanna, Suzan K., Ross, Charlene, Habibi, Sohrab, Zamboni, Beth, Müller, Markus, Brunner, Martin, Sharpless, Norman E., Zamboni, William C.
Publié 2012

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

par Dillon, Patrick M., Petroni, Gina R., Smolkin, Mark E., Brenin, David R., Chianese-Bullock, Kimberly A., Smith, Kelly T., Olson, Walter C., Fanous, Ibrahim S., Nail, Carmel J., Brenin, Christiana M., Hall, Emily H., Slingluff, Craig L.
Publié dans J Immunother Cancer (2017)

Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

par Roberts, Patrick J., Usary, Jerry E., Darr, David B., Dillon, Patrick M., Pfefferle, Adam D., Whittle, Martin C., Duncan, James S., Johnson, Soren M., Combest, Austin J., Jin, Jian, Zamboni, William C., Johnson, Gary L., Perou, Charles M., Sharpless, Norman E.
Publié 2012

Association of Incident Amelanotic Melanoma with Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma

par Vernali, Steven, Waxweiler, Weston T., Dillon, Patrick M., Kanetsky, Peter A., Orlow, Irene, Luo, Li, Busam, Klaus J., Kricker, Anne, Armstrong, Bruce K., Anton-Culver, Hoda, Gruber, Stephen B., Gallagher, Richard P., Zanetti, Roberto, Rosso, Stefano, Sacchetto, Lidia, Dwyer, Terence, Cust, Anne E., Ollila, David W., Begg, Colin B., Berwick, Marianne, Thomas, Nancy E.
Publié dans JAMA Dermatol (2017)

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study

par Thomas, Nancy E., Kricker, Anne, Waxweiler, Weston T., Dillon, Patrick M., Busam, Klaus J., From, Lynn, Groben, Pamela A., Armstrong, Bruce K., Anton-Culver, Hoda, Gruber, Stephen B., Marrett, Loraine D., Gallagher, Richard P., Zanetti, Roberto, Rosso, Stefano, Dwyer, Terence, Venn, Alison, Kanetsky, Peter A., Orlow, Drs. Irene, Paine, Susan, Ollila, David W., Reiner, Anne S., Luo, Li, Hao, Honglin, Frank, Jill S., Begg, Colin B., Berwick, Marianne
Publié dans JAMA Dermatol (2014)

A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-t...

par Jovanović, Bojana, Mayer, Ingrid A., Mayer, Erica L., Abramson, Vandana G., Bardia, Aditya, Sanders, Melinda E., Kuba, M. Gabriela, Estrada, Monica V., Beeler, J. Scott, Shaver, Timothy M., Johnson, Kimberly C., Sanchez, Violeta, Rosenbluth, Jennifer M., Dillon, Patrick M., Forero-Torres, Andres, Chang, Jenny C., Meszoely, Ingrid M., Grau, Ana M., Lehmann, Brian D., Shyr, Yu, Sheng, Quanhu, Chen, Sheau-Chiann, Arteaga, Carlos L., Pietenpol, Jennifer A.
Publié dans Clin Cancer Res (2017)